• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARTEGRAFT, INC ARTEGRAFT; COLLAGEN VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARTEGRAFT, INC ARTEGRAFT; COLLAGEN VASCULAR GRAFT Back to Search Results
Model Number AG640
Device Problem Contamination /Decontamination Problem (2895)
Patient Problem Post Operative Wound Infection (2446)
Event Date 12/11/2017
Event Type  Injury  
Manufacturer Narrative
Patient 2 of 2.Refer to mdr's 2247686-2018-00002 and 2247686-2018-00003 for patient 1 of 2.The artegraft (collagen vascular grafts) was not returned to artegraft, inc.For evaluation.A review of the production batch record was performed; no anomalies were identified.All grafts released from product batch 17g218 passed all of the requirements including pressure testing and sterility testing prior to final release to finished goods.In follow-up conversations between the distributor representative and the surgeons' staff at (b)(6) hospital, it was stated that the tamper evident seal was in place on the box , the shrink wrap was present on the tube prior to use, and the graft was prepared per the ifu prior to use.Artegraft, inc.Chief medical officer (qualification: m.D., f.A.C.S.) reviewed the case details and stated that " in the event that a wound infection occurs in the area of the artegraft, increased surveillance must be undertaken.Graft is collagen.Collagen may break down in the presence of pseudomonas, mrsa, e.Coli." artegraft, inc.Ifu dosage and administration section provides instructions for aseptically removing the artegraft from its container.Additionally, the adverse reaction section states "disruption of anastomoses, especially in the presence of infection, has been observed and, in a few cases, transient low grade fever, the etiology, of which has not been obvious, has been experienced." no confirmed complaint trend was identified related to the issue.All product quality and clinical issues will continue to be monitored within artegraft, inc.Quality systems, quality assurance trending.
 
Event Description
Artegraft, inc.Received an email from an approved distributor representative on behalf of a vascular surgeon (dr.(b)(6)) stating that he recently had 2 patients that acquired infections roughly 2 weeks post-op artegraft (collagen vascular graft) implant for peripheral use.This file will capture patient 2 of 2.On (b)(6) 2017 the patient had an artegraft implanted for femoral popliteal at the right knee.The patient presented to the er at (b)(6) on (b)(6) 2017 with infection, fever, severely septic and tested positive for multiple infections at distal/proximal end of graft.After 2 days ((b)(6) 2017) the patient was transferred to (b)(6) to dr.(b)(6) for surgery.On (b)(6) 2017 dr.(b)(6) dictation says: incision, drainage and washout of right lower extremity thigh and groin.Applied wound vac.Antibiotic bead placement right thigh and groin.Right thigh muscle flap coverage of graft.Infection species was not noted.No information was provided regarding status of graft after the patient was transferred back to the nursing home.No notes of graft failure.Patient is reportedly back at the hospital for "other reasons".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTEGRAFT
Type of Device
COLLAGEN VASCULAR GRAFT
Manufacturer (Section D)
ARTEGRAFT, INC
206 north center drive
north brunswick NJ 08902 4247
Manufacturer (Section G)
ARTEGRAFT, INC.
206 north center drive
north brunswick NJ 08902 4247
Manufacturer Contact
cynthia salter
206 north center drive
north brunswick, NJ 08902-4247
7324228333
MDR Report Key7247267
MDR Text Key99199019
Report Number2247686-2018-00004
Device Sequence Number1
Product Code LXA
UDI-Device Identifier00316837000244
UDI-Public(01)00316837000244(17)200831(10)17G218-001
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
N16837
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial
Report Date 02/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/07/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date08/31/2020
Device Model NumberAG640
Device Catalogue NumberAG640
Device Lot Number17G218-001
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/08/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/06/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age63 YR
-
-